rs11154727

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000355286.12(EYA4):​c.278-1572T>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.179 in 152,060 control chromosomes in the GnomAD database, including 2,714 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.18 ( 2714 hom., cov: 32)

Consequence

EYA4
ENST00000355286.12 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -1.81

Publications

2 publications found
Variant links:
Genes affected
EYA4 (HGNC:3522): (EYA transcriptional coactivator and phosphatase 4) This gene encodes a member of the eyes absent (EYA) family of proteins. The encoded protein may act as a transcriptional activator through its protein phosphatase activity, and it may be important for eye development, and for continued function of the mature organ of Corti. Mutations in this gene are associated with postlingual, progressive, autosomal dominant hearing loss at the deafness, autosomal dominant non-syndromic sensorineural 10 locus. The encoded protein is also a putative oncogene that mediates DNA repair, apoptosis, and innate immunity following DNA damage, cellular damage, and viral attack. Defects in this gene are also associated with dilated cardiomyopathy 1J. Alternative splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Jul 2014]
EYA4 Gene-Disease associations (from GenCC):
  • autosomal dominant nonsyndromic hearing loss 10
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), PanelApp Australia
  • nonsyndromic genetic hearing loss
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • autosomal dominant nonsyndromic hearing loss
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • dilated cardiomyopathy 1J
    Inheritance: AD Classification: SUPPORTIVE, LIMITED Submitted by: Orphanet, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.309 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: ENST00000355286.12. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYA4
NM_004100.5
MANE Select
c.278-1572T>C
intron
N/ANP_004091.3
EYA4
NM_001301013.2
c.278-1572T>C
intron
N/ANP_001287942.1
EYA4
NM_172105.4
c.278-1572T>C
intron
N/ANP_742103.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYA4
ENST00000355286.12
TSL:1 MANE Select
c.278-1572T>C
intron
N/AENSP00000347434.7
EYA4
ENST00000531901.5
TSL:2
c.278-1572T>C
intron
N/AENSP00000432770.1
EYA4
ENST00000431403.3
TSL:5
c.209-1572T>C
intron
N/AENSP00000404558.3

Frequencies

GnomAD3 genomes
AF:
0.179
AC:
27258
AN:
151940
Hom.:
2717
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.107
Gnomad AMI
AF:
0.324
Gnomad AMR
AF:
0.176
Gnomad ASJ
AF:
0.218
Gnomad EAS
AF:
0.323
Gnomad SAS
AF:
0.246
Gnomad FIN
AF:
0.205
Gnomad MID
AF:
0.174
Gnomad NFE
AF:
0.200
Gnomad OTH
AF:
0.201
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.179
AC:
27250
AN:
152060
Hom.:
2714
Cov.:
32
AF XY:
0.181
AC XY:
13462
AN XY:
74340
show subpopulations
African (AFR)
AF:
0.106
AC:
4413
AN:
41538
American (AMR)
AF:
0.176
AC:
2683
AN:
15262
Ashkenazi Jewish (ASJ)
AF:
0.218
AC:
756
AN:
3468
East Asian (EAS)
AF:
0.322
AC:
1656
AN:
5150
South Asian (SAS)
AF:
0.247
AC:
1194
AN:
4828
European-Finnish (FIN)
AF:
0.205
AC:
2168
AN:
10570
Middle Eastern (MID)
AF:
0.163
AC:
48
AN:
294
European-Non Finnish (NFE)
AF:
0.200
AC:
13614
AN:
67934
Other (OTH)
AF:
0.201
AC:
423
AN:
2106
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
1101
2202
3303
4404
5505
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
306
612
918
1224
1530
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.193
Hom.:
4986
Bravo
AF:
0.178
Asia WGS
AF:
0.279
AC:
970
AN:
3476

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
0.016
DANN
Benign
0.60
PhyloP100
-1.8
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs11154727; hg19: chr6-133776122; API